Skip to main content

and
  1. No Access

    Article

    LMDS-1, a potential TrkB receptor agonist provides a safe and neurotrophic effect for early-phase Alzheimer’s disease

    The signaling pathways of tropomyosin-related kinase B (TrkB) receptor play a pivotal role in axonal sprouting, proliferation of dendritic arbor, synaptic plasticity, and neuronal differentiation. The levels o...

    Chia-Hao Fan, Chia-Wei Lin, Hei-Jen Huang, Guey-Jen Lee-Chen in Psychopharmacology (2020)

  2. No Access

    Article

    Targeting Inflammation, PHA-767491 Shows a Broad Spectrum in Protein Aggregation Diseases

    Many protein aggregation diseases (PAD) affect the nervous system. Deposits of aggregated disease-specific proteins are found within or around the neuronal cells of neurodegenerative diseases. Although the mai...

    Yu-Han Chung, Chia-Wei Lin, Hsin-Yu Huang in Journal of Molecular Neuroscience (2020)

  3. Article

    Open Access

    Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice

    Hyperglycemia accelerates the progression of Alzheimer’s disease (AD), and GSK3β plays a potential link between AD and hyperglycemia. Therefore, a direct or indirect GSK3β inhibition may have potential to dela...

    Hei-Jen Huang, Shu-Ling Chen, Hsin-Yu Huang, Ying-Chieh Sun in Psychopharmacology (2019)

  4. No Access

    Article

    Trehalose Attenuates the Gait Ataxia and Gliosis of Spinocerebellar Ataxia Type 17 Mice

    Spinocerebellar ataxia type 17 (SCA17) is caused by CAG/CAA repeat expansion on the gene encoding a general transcription factor, TATA-box-binding protein (TBP). The CAG repeat expansion leads to the reduced s...

    Zhi-Zhong Chen, Chien-Ming Wang, Guan-Chiun Lee, Ho-Chiang Hsu in Neurochemical Research (2015)